GlassScriptPhysician profile
Kellie D Souther
NPI 1558846527
$737.45
in general payments reported to CMS, 2019-2025
15 companies · $579 in 2025
The $579 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.26 · 2024: $109 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $168.25 | 2025 | |
| Novo Nordisk INC | $117.70 | 2022-2025 | Wegovy |
| Amgen INC. | $61.81 | 2025 | Otezla |
| Lilly USA, LLC | $60.78 | 2024-2025 | Mounjaro, Zepbound |
| Janssen Biotech, INC. | $50.98 | 2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $49.99 | 2025 | |
| Cipher Pharmaceuticals US LLC | $46.43 | 2025 | Spinosad, Natroba |
| Irhythm Technologies, INC. | $44.40 | 2024 | Zio Xt Patch, Zio Monitor |
| Shield Therapeutics INC | $27.68 | 2025 | |
| Ucb, INC. | $21.25 | 2025 | Bimzelx |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.41 | 2025 | Caplyta |
| Dynavax Technologies Corporation | $19.18 | 2025 | Heplisav-B |
| Pfizer INC. | $16.97 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $16.35 | 2025 | Airsupra |
| Organon LLC | $16.27 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Souther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.